Cargando…
Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2
Anoctamin 5 (ANO5) is a member of the Anoctamin (ANO) family of calcium-activated chloride channels. Although ANO5 expression is upregulated in various cancers, its role in osteosarcoma remains largely unknown. In this study, bioinformatics analysis, western blot, and immunohistochemical staining re...
Autores principales: | Pan, Runsang, Lu, Qiaoying, Ren, Chong, Li, Hao, Zeng, Fanqiang, Tian, Xiaobin, Chen, Houping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312408/ https://www.ncbi.nlm.nih.gov/pubmed/34238763 http://dx.doi.org/10.18632/aging.203212 |
Ejemplares similares
-
CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021) -
MicroRNA-145-5p inhibits osteosarcoma cell proliferation by targeting E2F transcription factor 3
por: Li, Hao, et al.
Publicado: (2020) -
Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway
por: Ren, Chong, et al.
Publicado: (2020) -
A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
por: Pan, Runsang, et al.
Publicado: (2022) -
LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Deng, Biyong, et al.
Publicado: (2021)